Norbert Pfeiffer Selected Research

Prostaglandins

1/2020	Schirmer test results: are they associated with topical or systemic medication?
12/2014	A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components.
9/2014	Fixed-dose combination of tafluprost and timolol in the treatment of open-angle glaucoma and ocular hypertension: comparison with other fixed-combination products.
1/2011	Addition of a fixed combination of brinzolamide 1%/timolol 0.5% to prostaglandin monotherapy in patients with glaucoma or ocular hypertension.
5/2010	Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication.
3/2006	Endothelin antagonism: effects of FP receptor agonists prostaglandin F2alpha and fluprostenol on trabecular meshwork contractility.
8/2002	Histology and fine structure of the iris and outflow system following latanoprost therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Norbert Pfeiffer Research Topics

Disease

105	Glaucoma 05/2024 - 09/2002
28	Open-Angle Glaucoma (Glaucoma, Open Angle) 11/2023 - 08/2002
15	Macular Degeneration (Age-Related Maculopathy) 05/2024 - 05/2007
15	Ocular Hypertension (Glaucoma, Suspect) 01/2022 - 09/2002
13	Dry Eye Syndromes (Dry Eye Syndrome) 03/2024 - 03/2005
11	Blister (Bulla) 05/2024 - 08/2006
11	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 01/2014
10	Hypertension (High Blood Pressure) 11/2023 - 01/2016
10	Cataract (Cataracts) 06/2023 - 01/2002
9	Inflammation (Inflammations) 03/2024 - 06/2012
7	Refractive Errors (Refractive Error) 06/2023 - 09/2002
6	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2023 - 03/2006
5	Optic Nerve Diseases (Optic Neuropathy) 07/2023 - 08/2013
5	Obesity 01/2023 - 06/2017
4	Fibrosis (Cirrhosis) 03/2024 - 01/2020
4	Type 2 Diabetes Mellitus (MODY) 10/2023 - 01/2016
4	Neoplasms (Cancer) 07/2023 - 08/2012
4	Strabismus (Squint) 06/2023 - 09/2005
4	Vascular Diseases (Vascular Disease) 06/2022 - 12/2019
4	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 04/2002
4	Myopia 05/2021 - 01/2020
4	Coronary Artery Disease (Coronary Atherosclerosis) 02/2021 - 04/2015
4	Low Tension Glaucoma 01/2021 - 08/2005
4	Myocardial Infarction 10/2019 - 04/2015
4	Hemorrhage 12/2017 - 08/2007
3	Keratoconus 11/2023 - 01/2018
3	Eye Diseases (Eye Disease) 01/2023 - 08/2007
3	Astigmatism 01/2023 - 12/2017
3	Ganglion Cysts (Ganglion) 04/2022 - 10/2018
3	Body Weight (Weight, Body) 05/2020 - 04/2014
3	Vision Disorders (Hemeralopia) 01/2020 - 04/2019
3	Stroke (Strokes) 10/2019 - 12/2016
3	Blindness (Hysterical Blindness) 09/2019 - 01/2013
3	Ischemia 09/2019 - 06/2011
3	Hypoxia (Hypoxemia) 01/2019 - 01/2018
3	Heart Failure 06/2017 - 09/2016
3	Necrosis 01/2017 - 11/2012
3	Multiple Sclerosis 01/2013 - 04/2008
2	Retinal Diseases 05/2024 - 06/2023
2	Mitochondrial Diseases (Mitochondrial Disease) 02/2024 - 08/2019
2	Corneal Opacity 01/2024 - 01/2017
2	Atherosclerosis 12/2023 - 09/2023
2	Insulin Resistance 10/2023 - 10/2021
2	Reperfusion Injury 04/2023 - 01/2021
2	Keratitis 12/2022 - 06/2022
2	Retinopathy of Prematurity (Retrolental Fibroplasia) 12/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

45	Retinaldehyde (Retinal)IBA 11/2023 - 08/2005
30	AutoantibodiesIBA 01/2024 - 06/2003
29	Proteins (Proteins, Gene)FDA Link 05/2024 - 03/2005
24	Biomarkers (Surrogate Marker)IBA 02/2023 - 03/2005
18	AntibodiesIBA 11/2022 - 04/2002
18	AntigensIBA 10/2022 - 06/2003
11	Immunoglobulin G (IgG)IBA 02/2023 - 08/2005
11	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2023 - 06/2008
9	Timolol (Blocadren)FDA LinkGeneric 01/2019 - 12/2010
7	Ophthalmic Solutions (Eye Drops)IBA 07/2023 - 12/2010
7	ProstaglandinsIBA 01/2020 - 08/2002
7	ProteomeIBA 05/2019 - 01/2012
6	Peptides (Polypeptides)IBA 01/2023 - 03/2005
6	dorzolamide (Trusopt)FDA LinkGeneric 01/2022 - 09/2002
6	tafluprostIBA 01/2017 - 05/2010
5	AntioxidantsIBA 12/2023 - 01/2019
5	LipidsIBA 11/2023 - 09/2011
5	Latanoprost (Xalatan)FDA Link 01/2019 - 08/2002
5	Crystallins (Crystallin)IBA 10/2018 - 06/2011
4	CytokinesIBA 03/2024 - 09/2011
4	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2023 - 01/2019
4	EnzymesIBA 02/2023 - 01/2018
4	Thrombin FDA Link 06/2022 - 01/2018
4	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 01/2016
3	SteroidsIBA 11/2023 - 01/2020
3	Triglycerides (Triacylglycerol)IBA 10/2023 - 01/2018
3	Fluocinolone Acetonide (Capex)FDA LinkGeneric 09/2022 - 01/2019
3	CollagenIBA 07/2019 - 02/2010
3	Neuroprotective AgentsIBA 11/2017 - 08/2013
3	GATIBA 01/2017 - 10/2006
2	Complement System Proteins (Complement)IBA 02/2024 - 04/2002
2	Apolipoproteins E (ApoE)IBA 12/2023 - 09/2023
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2023 - 01/2018
2	Hypoglycemic Agents (Hypoglycemics)IBA 11/2023 - 01/2023
2	HDL CholesterolIBA 10/2023 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 12/2022
2	ApolipoproteinsIBA 09/2023 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2023 - 01/2017
2	Antidepressive Agents (Antidepressants)IBA 01/2023 - 01/2022
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023 - 01/2022
2	DiureticsIBA 01/2023 - 08/2007

Therapy/Procedure

30	Therapeutics 01/2024 - 12/2004
25	Trabeculectomy (Trabeculoplasty) 10/2023 - 01/2002
7	Lasers (Laser) 01/2021 - 11/2011
5	Sutures (Suture) 01/2019 - 06/2008
4	Slit Lamp 01/2024 - 11/2011
4	Operative Surgical Procedures 11/2023 - 01/2017
4	Intravitreal Injections 04/2022 - 08/2012
4	Contact Lenses 04/2013 - 06/2012
3	Filtering Surgery 05/2024 - 02/2010
3	Laser Therapy (Surgery, Laser) 01/2021 - 01/2020
2	Drug Therapy (Chemotherapy) 02/2024 - 01/2021
2	Penetrating Keratoplasty 01/2024 - 12/2022
2	Injections 07/2023 - 01/2017